DF
ELV icon

Dunhill Financial’s Elevance Health ELV Stock Holding History

Dunhill Financial’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.39K Buy
6
+2
+50% +$742 ﹤0.01% 813
2026
Q1 		$1.41K Sell
4
-3
-43% -$986 ﹤0.01% 891
2025
Q4 		$2.46K Buy
7
+2
+40% +$676 ﹤0.01% 708
2025
Q3 		$1.65K Sell
5
-7
-58% -$2.18K ﹤0.01% 721
2025
Q2 		$4.82K Sell
12
-10
-45% -$4.02K ﹤0.01% 551
2025
Q1 		$9.62K Buy
22
+6
+38% +$2.41K ﹤0.01% 428
2024
Q4 		$5.74K Sell
16
-55
-77% -$23K ﹤0.01% 516
2024
Q3 		$37K Buy
71
+26
+58% +$13.9K 0.02% 196
2024
Q2 		$24.5K Buy
45
+23
+105% +$12.2K 0.02% 192
2024
Q1 		$11.6K Buy
22
+3
+16% +$1.49K 0.01% 216
2023
Q4 		$9.11K Buy
+19
New +$8.79K 0.01% 221

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Dunhill Financial's ELV Position: Q2 2026 in Review

Dunhill Financial increased its Elevance Health (ELV) stake by 50% in Q2 2026, buying an estimated $742 and bringing the position to 6 shares worth $2.39K. The position accounts for ﹤0.01% of the portfolio, ranked #813.

Dunhill Financial first reported a position in ELV in Q4 2023 and has held it in 11 quarters since. The position peaked at $37K in Q3 2024. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Dunhill Financial held 6 shares of Elevance Health worth $2.39K as of Q2 2026.
  • Dunhill Financial bought 2 Elevance Health shares in Q2 2026, an estimated $742.
  • Elevance Health made up ﹤0.01% of Dunhill Financial's portfolio in Q2 2026, its #813 holding.
  • Dunhill Financial first reported a position in Elevance Health in Q4 2023 and has held it in 11 quarters since.
  • Dunhill Financial's Elevance Health position peaked at $37K in Q3 2024.
  • 1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Dunhill Financial's 13F filing for Q2 2026, filed 7 Aug 2026.